InnoCare Pharma Limited (INCPF)
PNK: INCPF
· Real-Time Price · USD
3.26
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 3.26 |
| Market Cap | 4.88B |
| Revenue (ttm) | 777.73M |
| Net Income (ttm) | -470.89M |
| EPS (ttm) | -0.03 |
| PE Ratio (ttm) | -108.67 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.26 |
| Volume | 900 |
| Avg. Volume (20D) | 352.5 |
| Open | 3.26 |
| Previous Close | 3.26 |
| Day's Range | 3.26 - 3.26 |
| 52-Week Range | 3.26 - 3.26 |
| Beta | 1.11 |
About INCPF
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 9, 2021
Employees 1,089
Stock Exchange PNK
Ticker Symbol INCPF
Website https://www.innocarepharma.com